EUVIMEDEUVIMED entdecken
Kohortenstudie

Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study

Shuwei Zhang, Houpu Yang, Yaqian Xu, Shu Wang

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07340-8 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Shuwei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Breast Center, Peking University People's Hospital, Xizhimen South Street No. 11, Xicheng District, Beijing, 100044, China. Hauptthemen laut MEDLINE: Neoplasm Staging, Propensity Score, Neoplasm Recurrence, Local, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The aim of the study was to explore the role of recurrent TNM (rTNM) staging in predicting prognosis for ipsilateral breast tumor recurrence (IBTR) and determine the optimal treatment strategy for IBTR. METHOD: IBTR cases were identified from the Surveillance, Epidemiology, and End Results (SEER) database spanning the years 2000-2018. Cox proportional hazards analysis was performed to examine factors associated with overall survival (OS) and breast cancer-specific survival (BCSS). Propensity score matching (PSM) was employed to match IBTR with primary early breast cancer (EBC) based on clinicopathological characteristics. Investigations into the impact of different therapies were also included. RESULTS: Of the 4375 IBTR cases included in the study, the 5-year OS was 87.1%, 71.6% and 58.7% in rTNM stages I, II and III, respectively. After PSM, while IBTR patients had worse survival to primary EBC patients, prognosis of IBTR for different rTNM stage always closely aligned with the corresponding stage of primary EBC. Repeat breast-conserving surgery (BCS) with radiation therapy was equivalent to mastectomy with respect to OS and BCSS. Chemotherapy was favorable for OS and BCSS in estrogen receptor (ER)-negative IBTR or IBTR occurring within a 60-month interval. CONCLUSIONS: rTNM staging system has an outstanding prognostic value for survival outcome of patients with IBTR, and IBTR and primary EBC may have potentially analogous features in the context of TNM staging. BCS plus radiation therapy may be an alternative. IBTR cases who have experienced recurrence with short intervals and with ER-negative tumors might benefit from chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasm StagingPropensity ScoreNeoplasm Recurrence, LocalBreast NeoplasmsSEER ProgramHumansFemaleMiddle AgedPrognosisAgedAdultMastectomy, Segmental

Stichwörter der Autor:innen

Breast cancerChemotherapyClinical stagingIpsilateral breast tumor recurrenceLocal recurrenceSurgerySurvival

Autor:innen und Institutionen

  • Breast Center, Peking University People's Hospital, Xizhimen South Street No. 11, Xicheng District, Beijing, 100044, China.
  • Breast Center, Peking University People's Hospital, Xizhimen South Street No. 11, Xicheng District, Beijing, 100044, China. shuwang@pkuph.edu.cn.

Zitieren

APA

Zhang, S., Yang, H., Xu, Y., & Wang, S. (2024). Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07340-8

Vancouver

Zhang S, Yang H, Xu Y, Wang S. Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07340-8

BibTeX
@article{Zhang2024,
  author = {Zhang, Shuwei and Yang, Houpu and Xu, Yaqian and Wang, Shu},
  title = {Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07340-8}
}
Kostenlos starten →